News

SUDOSCAN included in Polish Guidelines for the management of diabetic patients

News / By

Sudoscan in the “2016 Guidelines on the management of diabetic patients. A position of Diabetes Poland.” (English excerpt of the publication) Araszkiewicz A et al. 2016 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Diabetologia Kliniczna 2016, tom 5, supl. A “The guidelines are a product of a team of nearly …

SUDOSCAN included in Polish Guidelines for the management of diabetic patients Read More »

Journée du Diabète : Conférence de presse « Espace Diabète »

News, Press review / By

14 Novembre 2016, Journée du Diabète   Impeto Medical et ProPharma ont organisé une conférence de presse afin de présenter « Espace Diabète » à la presse spécialisée et grand public. Impeto Medical, créateur, développeur et fabricant d’EZscan et SUDOSCAN, et son distributeur en pharmacie, ProPharma, présentent Espace Diabète, une solution pour permettre aux pharmacies …

Journée du Diabète : Conférence de presse « Espace Diabète » Read More »

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

To receive our latest scientific news:

Website dedicated
to health professionals

I am a health professional

Scroll to Top